FSD Pharma Inc. (CSE:HUGE,OTCQB:FSDDF,FRA:OK9) subsidiary FV Pharma has cut the ribbon for a historic building in Cobourg, Ontario that will house the city’s first cannabis dispensary. The building is located next to the former Kraft plant, where FV Pharma is developing its cultivation and processing facility. Company executives were joined by Cobourg Mayor Gil Brocanier as well as other local dignitaries.
In a recent article on the company’s upcoming dispensary, FV Pharma CEO Thomas Fairfull was quoted saying that the dispensary should be up and running in six to eight weeks. “The building is well over 100 years old and I think it is an important heritage site for Cobourg. It’s important for our company to support historical things in the town,” he said.
The building holds a wealth of history for the city, which originally produced Certo pectin. Brocanier himself even worked at the facility at one point in his career.
To him, the history of the building as a focus point of the community is what makes this transition so impactful. “That makes it really important and the fact that we’re going to have a dispensary here right on site, that will be accessible to the people in this whole area, is just a bonus,” Brocanier said. “We’re expecting great things from the medical marijuana cultivation, as well as the products that they are going to have available here.”
To read the full article, click here.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .